DrugPatentWatch Database Preview

Sun Pharm Company Profile

SUN PHARM has five hundred and two approved drugs.

There are twenty-nine US patents protecting SUN PHARM drugs. There are nine tentative approvals on SUN PHARM drugs.

There are two hundred and seventy-nine patent family members on SUN PHARM drugs in fifty-six countries and four hundred and six supplementary protection certificates in sixteen countries.

International Patents:	279
US Patents:	29
Tradenames:	320
Ingredients:	294
NDAs:	502
Patent Litigation for Sun Pharm:	See patent lawsuits for Sun Pharm
PTAB Cases with Sun Pharm as petitioner:	See PTAB cases with Sun Pharm as petitioner

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm	TADALAFIL	tadalafil	TABLET;ORAL	208934-002	Mar 26, 2019	AB	RX	No	No		Start Trial				Start Trial
Sun Pharm Industries	METHYLDOPA	methyldopa	TABLET;ORAL	070073-001	Oct 9, 1986		DISCN	No	No		Start Trial				Start Trial
Sun Pharm Industries	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	TABLET;ORAL	090217-001	Jan 29, 2016	AB	RX	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharm Inds Inc	LAC-HYDRIN	ammonium lactate	LOTION;TOPICAL	019155-001	Apr 24, 1985	4,105,783	Start Trial
Sun Pharm Industries	BACTRIM DS	sulfamethoxazole; trimethoprim	TABLET;ORAL	017377-002	Approved Prior to Jan 1, 1982	RE28636	Start Trial
Sun Pharm Inds Inc	ULTRAVATE	halobetasol propionate	OINTMENT;TOPICAL	019968-001	Dec 17, 1990	4,619,921	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-01-07
➤ Subscribe	Capsules	35 mg	➤ Subscribe	2015-11-25
➤ Subscribe	Tablets	125 mg	➤ Subscribe	2018-07-23
➤ Subscribe	Injection	250 mcg/0.5 mL, 1 mL PFS	➤ Subscribe	2012-03-30
➤ Subscribe	Capsules	30 mg and 40 mg	➤ Subscribe	2012-12-31
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-06-19
➤ Subscribe	Capsules	25 mg	➤ Subscribe	2016-05-16

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2236132	C300714	Netherlands	Start Trial	PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718
0321122	2/1997	Austria	Start Trial	PRODUCT NAME: TOPOTECAN; NAT. REGISTRATION NO/DATE: EU/1/96/027/001 EU/1/96/027/002 19961112; FIRST REGISTRATION: LI 53857 01 19961016
0193926	SPC/GB98/041	United Kingdom	Start Trial	PRODUCT NAME: RIVASTIGMINE, AS FREE BASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: CH 5427501 19970731; CH 5427502 19970731; CH 5427503 19970731; CH 5427504 19970731; CH 5427505 19970731; CH 5427506 19970731; UK EU/1/98/066/001 19980512; UK EU/1/98/066/002 19980512; UK EU/1/98/066/003 19980512; UK EU/1/98/066/004 19980512; UK EU/1/98/066/005 19980512; UK EU/1/98/066/006 19980512; UK EU/1/98/092/023 19980512; UK EU/1/98/092/024 19980512; UK EU/1/98/092/025 19980512; UK EU/1/98/092/026 19980512; UK EU/1/98/066/025 19980512; UK EU/1/98/066/026 19980512; UK EU/1/98/092/019 19980512; UK EU/1/98/092/020 19980512; UK EU/1/98/092/021 19980512; UK EU/1/98/092/022 19980512; UK EU/1/98/0
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.